Replimune's skin cancer therapy fails in mid-stage study, shares plunge

(Reuters) - Replimune Group said on Tuesday its experimental combination therapy to treat a common form of skin cancer failed to significantly remove ...

Related Keywords

Bengaluru ,Karnataka ,India ,Arun Koyyur ,Sriraj Kalluvila ,Reuters ,Replimune Group ,Mariam Sunny , ,